Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group (Q33502763)
scientific article published on June 1, 1998
Language:
Current Data About Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group
(P31) (Q13442814)
(P248)
(P698) 9626212
(P813) Thursday, July 27, 2017

(P304) 2126-2132
(P248)
(P698) 9626212
(P813) Thursday, July 27, 2017

(P407) (Q1860)

(P433) 6
(P248)
(P698) 9626212
(P813) Thursday, July 27, 2017

(P478) 16
(P248)
(P698) 9626212
(P813) Thursday, July 27, 2017

(P577) Monday, June 1, 1998
(P248)
(P698) 9626212
(P813) Thursday, July 27, 2017

Monday, June 1, 1998
(P248)
(P698) 9626212
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9626212
(P813) Thursday, December 26, 2024

(P921) (Q974135)
(P887)

(Q12322152)
(P887)

(P953) http://intl.jco.org/cgi/content/abstract/16/6/2126
(P6954)
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.6.2126
(P248)
(P356) 10.1200/JCO.1998.16.6.2126
(P854) https://api.crossref.org/works/10.1200/JCO.1998.16.6.2126
(P813) Thursday, December 26, 2024

(P1433) (Q400292)
(P248)
(P698) 9626212
(P813) Thursday, July 27, 2017

(P1476) "Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. The Japan Clinical Oncology Group" (language: en)
(P248)
(P698) 9626212
(P813) Thursday, July 27, 2017

(P2093) K. Furuse
(P1545) 1
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

M. Fukuoka
(P1545) 2
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

Y. Nishiwaki
(P1545) 3
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

Y. Kurita
(P1545) 4
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

K. Watanabe
(P1545) 5
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

K. Noda
(P1545) 6
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

Y. Ariyoshi
(P1545) 7
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

T. Tamura
(P1545) 8
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

N. Saijo
(P1545) 9
(P248)
(P698) 9626212
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9626212
(P813) Thursday, December 26, 2024

other details
description scientific article published on June 1, 1998

External Links
(P356) 10.1200/JCO.1998.16.6.2126
(P698) 9626212